Expert Interview
Reviewing the current treatment landscape for macular edema, with a focused look at Kodiak Sciences recent phase 3 data on Tarcocimab
Ticker(s): KOD, REGNInstitution: Speciality Eye Institute
- Vitreoretinal Surgeon who has been in practice for over 20 years.
- Treats between 70-100 patients with Macular Edema,
- Research and clinical studies focus on Macular Degeneration; member of several professional ophthalmologic groups and associations, including American Academy of Ophthalmology, American Society of Retina Specialist, and the Association for Research in Vision and Ophthalmology.
Please describe your background and practice setting
Added By: ben_adminHow many patients with Macular Edema do you treat monthly?
Added By: ben_adminWhat are your thoughts on the recent phase 3 data from Kodiak Science?
Added By: ben_adminCan you rate your excitement for Tarcocimab on a scale of 1-10?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
